• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化肝源性糖尿病与门脉高压和静脉曲张出血有关。

Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage.

机构信息

Department of Internal Medicine, Wonju College of Medicine, Wonju Christian Hospital, Yonsei University, 162, Ilsan-dong, Wonju, Republic of Korea.

出版信息

Dig Dis Sci. 2013 Nov;58(11):3335-41. doi: 10.1007/s10620-013-2802-y. Epub 2013 Aug 4.

DOI:10.1007/s10620-013-2802-y
PMID:23912248
Abstract

BACKGROUND AND AIM

The clinical impact and complications of hepatogenous diabetes (HD) on cirrhosis have not been elucidated. This study aimed to evaluate the relationship of HD with portal hypertension (PHT) and variceal hemorrhage and to assess the prevalence of HD.

METHODS

From July 2007 to December 2009, 75-g oral glucose tolerance test and insulin resistance (IR) were evaluated for 195 consecutive cirrhotic liver patients (M:F = 164:1, 53.0 ± 10.2 years) who had no history of diabetes mellitus. IR was calculated using the homeostasis model of assessment-insulin resistance (HOMA-IR) formula. Endoscopy for varices, hepatic venous pressure gradient (HVPG), and serologic tests were also conducted.

RESULTS

HD was observed in 55.4 % (108/194) of the patients. Among them, 62.0 % required OGTT for diagnosis because they did not show an abnormal fasting plasma glucose level. The presence of HD showed a significant correlation with high Child-Pugh's score, variceal hemorrhage, and HVPG (p = 0.004, 0.002, and 0.019, respectively). In multivariate analysis, Child-Pugh's score (OR 1.43, 95 % CI 1.005-2.038) and HVPG (OR 1.15, 95 % CI 1.003-2.547) had significant relationships with HD. Patients with recent variceal hemorrhages (within 6 months) exhibited significantly higher glucose levels at 120 min in OGTT compared to patients without hemorrhages (p = 0.042). However, there was no difference in fasting glucose levels. The 120-min glucose level and HOMA-IR score were significantly and linearly correlated with HVPG (r (2) = 0.189, p < 0.001 and r (2) = 0.033, p = 0.011, respectively).

CONCLUSION

HD and IR have significant relationships with PHT and variceal hemorrhage. Postprandial hyperglycemia in particular had a significant relationship with variceal hemorrhage.

摘要

背景与目的

肝源性糖尿病(HD)对肝硬化的临床影响和并发症尚未阐明。本研究旨在评估 HD 与门脉高压(PHT)和静脉曲张出血的关系,并评估 HD 的患病率。

方法

2007 年 7 月至 2009 年 12 月,对 195 例连续肝硬化患者(男:女=164:1,53.0±10.2 岁)进行 75g 口服葡萄糖耐量试验和胰岛素抵抗(IR)评估,这些患者均无糖尿病病史。采用稳态模型评估胰岛素抵抗(HOMA-IR)公式计算 IR。还进行了胃镜检查、肝静脉压力梯度(HVPG)和血清学检查。

结果

194 例患者中有 55.4%(108/194)存在 HD。其中,62.0%的患者需要 OGTT 进行诊断,因为他们的空腹血糖水平正常。HD 的存在与高 Child-Pugh 评分、静脉曲张出血和 HVPG 显著相关(p=0.004、0.002 和 0.019)。在多变量分析中,Child-Pugh 评分(OR 1.43,95%CI 1.005-2.038)和 HVPG(OR 1.15,95%CI 1.003-2.547)与 HD 有显著关系。有近期静脉曲张出血(6 个月内)的患者在 OGTT 120 分钟时的血糖水平明显高于无出血的患者(p=0.042)。然而,空腹血糖水平没有差异。120 分钟血糖水平和 HOMA-IR 评分与 HVPG 呈显著线性相关(r(2)=0.189,p<0.001 和 r(2)=0.033,p=0.011)。

结论

HD 和 IR 与 PHT 和静脉曲张出血有显著关系。餐后高血糖与静脉曲张出血有显著关系。

相似文献

1
Hepatogenous diabetes in cirrhosis is related to portal pressure and variceal hemorrhage.肝硬化肝源性糖尿病与门脉高压和静脉曲张出血有关。
Dig Dis Sci. 2013 Nov;58(11):3335-41. doi: 10.1007/s10620-013-2802-y. Epub 2013 Aug 4.
2
Hepatogenous Diabetes - A Report from Central India.肝源性糖尿病——来自印度中部的一份报告。
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):312-318. doi: 10.1016/j.jceh.2021.08.018. Epub 2021 Aug 25.
3
Predicting portal hypertension and variceal bleeding using non-invasive measurements of metabolic variables.利用代谢变量的无创测量预测门静脉高压和静脉曲张出血。
Ann Hepatol. 2013 Jul-Aug;12(4):588-98.
4
Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea.韩国多中心回顾性研究:肝硬化患者肝静脉压力梯度与首次静脉曲张出血的关系。
Clin Mol Hepatol. 2012 Dec;18(4):391-6. doi: 10.3350/cmh.2012.18.4.391. Epub 2012 Dec 21.
5
Relationship between portal pressure, esophageal varices, and variceal bleeding on the basis of the stage and cause of cirrhosis.基于肝硬化分期和病因的门静脉压力、食管静脉曲张及静脉曲张破裂出血之间的关系
Scand J Gastroenterol. 1997 Jul;32(7):731-5. doi: 10.3109/00365529708996526.
6
Application of a standardised protocol for hepatic venous pressure gradient measurement improves quality of readings and facilitates reduction of variceal bleeding in cirrhotics.应用标准化的肝静脉压力梯度测量方案可提高读数质量,并有助于减少肝硬化患者的静脉曲张出血。
Singapore Med J. 2016 Mar;57(3):132-7. doi: 10.11622/smedj.2016054.
7
Correlation of HVPG level with ctp score, MELD Score, ascites, size of varices, and etiology in cirrhotic patients.肝硬化患者中肝静脉压力梯度(HVPG)水平与Child-Turcotte-Pugh(CTP)评分、终末期肝病模型(MELD)评分、腹水、静脉曲张大小及病因的相关性。
Saudi J Gastroenterol. 2016 Mar-Apr;22(2):109-15. doi: 10.4103/1319-3767.164185.
8
Hepatic venous pressure gradient measurement in patients with liver cirrhosis: a correlation with disease severity and variceal bleeding.肝硬化患者肝静脉压力梯度测量:与疾病严重程度和静脉曲张出血的相关性
Medicina (Kaunas). 2009;45(1):8-13.
9
Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.肝静脉压力梯度可预测代偿期肝硬化患者的临床失代偿情况。
Gastroenterology. 2007 Aug;133(2):481-8. doi: 10.1053/j.gastro.2007.05.024. Epub 2007 May 21.
10
Perendoscopic variceal pressure measurement: a reliable estimation of portal pressure in patients with cirrhosis?经内镜曲张静脉压力测量:对肝硬化患者门静脉压力的可靠评估?
Gastroenterol Clin Biol. 2006 Aug-Sep;30(8-9):1012-8. doi: 10.1016/s0399-8320(06)73376-0.

引用本文的文献

1
Effect of diabetes on mortality and liver transplantation in alcoholic liver cirrhotic patients with acute decompensation.糖尿病对急性失代偿期酒精性肝硬化患者死亡率及肝移植的影响。
Hepatol Int. 2024 Oct;18(5):1579-1588. doi: 10.1007/s12072-024-10710-5. Epub 2024 Jul 17.
2
Burden of Portal Hypertension Complications Is Greater in Liver Transplant Wait-Listed Registrants with End-Stage Liver Disease and Type 2 Diabetes.终末期肝病和 2 型糖尿病的肝移植候补者中,门静脉高压并发症负担更大。
Dig Dis Sci. 2024 Sep;69(9):3554-3562. doi: 10.1007/s10620-024-08499-2. Epub 2024 Jul 10.
3
Hepatogenous Diabetes as Compared to Type-2 Diabetes Mellitus and Non-diabetes in Patients With Liver Cirrhosis: Magnitude, Characteristics, and Implications.

本文引用的文献

1
Revision and update on clinical practice guideline for liver cirrhosis.肝硬化临床实践指南的修订与更新
Korean J Hepatol. 2012 Mar;18(1):1-21. doi: 10.3350/kjhep.2012.18.1.1. Epub 2012 Mar 22.
2
Hemodynamic alterations in cirrhosis and portal hypertension.肝硬化和门静脉高压症中的血流动力学改变。
Korean J Hepatol. 2010 Dec;16(4):347-52. doi: 10.3350/kjhep.2010.16.4.347.
3
Hepatic venous pressure gradient can predict the development of hepatocellular carcinoma and hyponatremia in decompensated alcoholic cirrhosis.肝静脉压力梯度可预测失代偿期酒精性肝硬化患者发生肝细胞癌和低钠血症。
肝硬化患者中肝源性糖尿病与2型糖尿病及非糖尿病的比较:程度、特征及意义
J Clin Exp Hepatol. 2024 Sep-Oct;14(5):101411. doi: 10.1016/j.jceh.2024.101411. Epub 2024 Apr 9.
4
Predictors of Long-Term Rebleeding Risk in Cirrhotic Patients Undergoing Esophagogastric Devascularization and Splenectomy: Impact of Portal Vein Thrombosis and Hemoglobin Levels.食管胃静脉曲张断流术和脾切除术治疗肝硬化患者的长期再出血风险预测因素:门静脉血栓形成和血红蛋白水平的影响。
Med Sci Monit. 2023 Nov 1;29:e941153. doi: 10.12659/MSM.941153.
5
Hepatogenous diabetes: Knowledge, evidence, and skepticism.肝源性糖尿病:知识、证据与质疑。
World J Hepatol. 2022 Jul 27;14(7):1291-1306. doi: 10.4254/wjh.v14.i7.1291.
6
Hepatogenous Diabetes - A Report from Central India.肝源性糖尿病——来自印度中部的一份报告。
J Clin Exp Hepatol. 2022 Mar-Apr;12(2):312-318. doi: 10.1016/j.jceh.2021.08.018. Epub 2021 Aug 25.
7
Clinical implications of diabetes in chronic liver disease: Diagnosis, outcomes and management, current and future perspectives.糖尿病在慢性肝病中的临床意义:诊断、预后及管理,现状与未来展望
World J Gastroenterol. 2022 Feb 28;28(8):775-793. doi: 10.3748/wjg.v28.i8.775.
8
High Albumin Level Is Associated With Regression of Glucose Metabolism Disorders Upon Resolution of Acute Liver Inflammation in Hepatitis B-Related Cirrhosis.高白蛋白水平与乙型肝炎相关性肝硬化急性肝炎症消退后葡萄糖代谢紊乱的改善相关。
Front Cell Infect Microbiol. 2022 Feb 22;12:721138. doi: 10.3389/fcimb.2022.721138. eCollection 2022.
9
Hepatogenous Diabetes: A Primer.肝源性糖尿病:入门指南
J Clin Exp Hepatol. 2021 Sep-Oct;11(5):603-615. doi: 10.1016/j.jceh.2021.04.012. Epub 2021 May 1.
10
Association between Liver Cirrhosis and Diabetes Mellitus: A Review on Hepatic Outcomes.肝硬化与糖尿病之间的关联:关于肝脏结局的综述
J Clin Med. 2021 Jan 12;10(2):262. doi: 10.3390/jcm10020262.
Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1241-6. doi: 10.1097/MEG.0b013e32832a21c1.
4
Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.胰岛素抵抗是丙型肝炎病毒肝硬化患者发生食管静脉曲张的一个危险因素。
Hepatology. 2009 Jan;49(1):195-203. doi: 10.1002/hep.22655.
5
Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis.肝硬化患者食管胃静脉曲张及曲张静脉出血的预防与管理
Hepatology. 2007 Sep;46(3):922-38. doi: 10.1002/hep.21907.
6
Vascular endothelial dysfunction in cirrhosis.肝硬化中的血管内皮功能障碍
J Hepatol. 2007 May;46(5):927-34. doi: 10.1016/j.jhep.2007.02.006. Epub 2007 Mar 5.
7
Hepatic fibrosis, stellate cells, and portal hypertension.肝纤维化、星状细胞与门静脉高压症
Clin Liver Dis. 2006 Aug;10(3):459-79, vii-viii. doi: 10.1016/j.cld.2006.08.017.
8
Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.疾病机制:2型糖尿病中的肝脂肪变性——发病机制及临床意义
Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48. doi: 10.1038/ncpendmet0190.
9
Oral glucose tolerance test predicts prognosis of patients with liver cirrhosis.口服葡萄糖耐量试验可预测肝硬化患者的预后。
Am J Gastroenterol. 2006 Jan;101(1):70-5. doi: 10.1111/j.1572-0241.2005.00307.x.
10
Review article: type 2 diabetes and chronic liver disease in the Verona diabetes study.综述文章:维罗纳糖尿病研究中的2型糖尿病与慢性肝病
Aliment Pharmacol Ther. 2005 Nov;22 Suppl 2:24-7. doi: 10.1111/j.1365-2036.2005.02590.x.